Pharma & Biotech

French vaccine specialist Valneva has unveiled its full-year 2025 results, presenting a nuanced financial picture that underscores a significant improvement...

The biotech firm Ocugen has staged a remarkable recovery in recent months, capturing renewed attention from institutional investors. This resurgence...

In a move that sent shockwaves through the market, global banking giant HSBC has downgraded its stance on Eli Lilly...

The telehealth company Hims & Hers has taken a decisive step into the competitive GLP-1 market. It has now opened...

Biopharmaceutical firm CytomX Therapeutics has positioned itself for a significant clinical push following a substantial equity raise. The company confirmed...

For shareholders of Gene Biotherapeutics, the wait for substantive news continues. The company, formerly known as Taxus Cardium Pharmaceuticals Group,...

The biopharmaceutical giant AbbVie finds itself navigating a complex landscape where promising research initiatives are counterbalanced by resurgent legal challenges....

Precision Biosciences is solidifying its clinical development strategy, with a pivotal trial for a Duchenne muscular dystrophy (DMD) treatment taking...

Recent clinical trial data from Ocular Therapeutix has generated significant attention within ophthalmology investment circles. The company's key drug candidate,...

Iqvia Holdings Inc. is accelerating the digital transformation of the life sciences sector through a strategic technology alliance. The company...